Episode
How AI Is Detecting Lung Cancer From a Single CT Scan
- Published
- Jul 10, 2026
- Duration seconds
- 603
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/healthtech-talks-with-fexingo-digital-health-telemedicine-and-medical-software-7871821/episodes/how-ai-is-detecting-lung-cancer-from-a-single-ct-scan/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/healthtech-talks-with-fexingo-digital-health-telemedicine-and-medical-software-7871821/how-ai-is-detecting-lung-cancer-from-a-single-ct-scan.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode of Healthtech Talks with Fexingo, Lucas and Luna explore how artificial intelligence is transforming lung cancer detection. They focus on a breakthrough AI system developed at the University of Cambridge that can identify malignant lung nodules from a single CT scan with greater accuracy than human radiologists alone. The conversation covers the training dataset of 10,000 scans, the AI's 94% sensitivity rate, and how it reduces unnecessary biopsies by 40%. Lucas explains the underlying deep learning architecture, while Luna questions integration challenges in clinical workflows. They discuss the impact on early-stage diagnosis, where five-year survival rates exceed 70%, and the regulatory hurdles for FDA approval. The episode also touches on the role of healthtech startups in commercializing such tools, and the balance between automation and radiologist oversight. #AI #LungCancer #CTScan #DeepLearning #Radiology #EarlyDetection #Healthtech #UniversityOfCambridge #MedicalImaging #CancerDiagnosis #Startup #Regulation #FDA #ClinicalWorkflow #PatientOutcomes #Business #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo